Your shopping cart is currently empty

MIK665 (S-64315) (S-64315) has an inhibitory effect on myeloid leukemia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $135 | In Stock | In Stock | |
| 5 mg | $289 | In Stock | In Stock | |
| 10 mg | $455 | In Stock | In Stock | |
| 25 mg | $753 | In Stock | In Stock | |
| 50 mg | $1,060 | In Stock | In Stock | |
| 100 mg | $1,430 | In Stock | In Stock | |
| 500 mg | $2,860 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $438 | In Stock | In Stock |
| Description | MIK665 (S-64315) (S-64315) has an inhibitory effect on myeloid leukemia. |
| Targets&IC50 | leukocytes (sensitive):5.4 nM, MCL1:1.81 nM, leukocytes (intermediate):45 nM, leukocytes (resistant):134.8 nM, H9 cells:250 nM |
| In vitro | MIK665 (S-64315) had a synergistic effect when combined with ABT-199. Combined treatment with S64315 (0.156-10 μM) and ABT-199 (625 nM) reduced the cell viability of MB2141, MB3616, MB3961, MB4667, A375 and 1205Lu cells. The IC50 of MIK665 interaction with H929 cells was 250 nM[1]. |
| Cell Research | MIK665 suppresses H929 cells (IC50: 250 nM). |
| Synonyms | S-64315 |
| Molecular Weight | 875.41 |
| Formula | C47H44ClFN6O6S |
| Cas No. | 1799631-75-6 |
| Smiles | COc1ccccc1-c1nccc(COc2ccccc2C[C@@H](Oc2ncnc3sc(c(-c4ccc(OCCN5CCN(C)CC5)c(Cl)c4C)c23)-c2ccc(F)cc2)C(O)=O)n1 |
| Relative Density. | 1.324 g/cm3 (Predicted) |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 250 mg/mL (285.58 mM), Sonication is recommended. H2O: Insoluble, insoluble | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (5.71 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.